Episurf Episurf
  • English
  • Swedish
  • Home
  • Career
  • Contact us
  • Media
  • µiFidelity
  • Patients
  • Healthcare Professionals
  • Investors
  • About Episurf
  • News
  • Newsletter
  • EPIC-Knee
  • Home
  • Career
  • Contact us
  • Media
  • µiFidelity
  • English
  • Swedish

AGM 2019

  • Investor information
    • Statement from the CEO
    • The Episurf Share
      • Stock Quote
      • Share Capital
      • Insider Transactions
    • Shareholders
    • Reports
    • Press Releases
    • Financial Calendar
    • Subscription
    • Events & Presentations
    • Analyst Coverage
    • Financing incl. Prospectus
      • Directed Issue 2021
      • Rights Issue 2020
      • Rights Issue 2020
      • Financing from L1 Capital
      • Previous Prospectus
    • Contact Investor Relations
  • Corporate Governance
    • General Meeting
      • AGM 2023
      • AGM 2022
      • AGM 2021
      • AGM 2020
      • Extra general meeting 2020
      • Extra general meeting 2019
      • AGM 2019
      • Extra general meeting 2018
      • AGM 2018
      • AGM 2017
      • Extra General Meeting 2017
      • AGM 2016
      • Extra General Meeting 2016
      • General Meetings 2015
      • Previous Meetings
    • The Board
      • Board of Directors
      • Member’s Independence and Dependence
      • The Board’s Fee
      • The Board’s Work
      • Compensation Committee
    • The Nomination Committee
    • Episurf Management
      • Remuneration Guidelines for Senior Management
    • Advisors
    • Articles of Association
    • Corporate Governance Report
    • Internal Control
      • Control Environment
      • Risk Assessment
      • Control Activities
      • Information and Communication
      • Follow-up
    • Auditor

Episurf Medical’s Annual General Meeting was held on Monday, April 8, 2019 at 10:00 at Karlavägen 60, 114 49 Stockholm

 

Documents:


  •  Minutes 20190408
  •  Notice AGM 2019 20190307
  •  Nomination Committee Proposal 20190307
  •  Power of Attorney 20190311
  •  Auditor’s opinion under Chapter 8 Section 54 of of the Swedish Companies Act (2005:551) 20190318
  •  THE BOARD OF DIRECTORS’ OF EPISURF MEDICAL AB (PUBL) COMPENSATION COMMITTEE’S ASSESSMENT PURSUANT TO THE SWEDISH CODE OF CORPORATE GOVERNANCE 20190318
  •  Reason for deviation from the shareholder’s preferential rights, costs, et cetera 20190318
  •  The proposal of the Board of Directors of Episurf Medical AB (publ) for resolutions on (A) adoption of an employee stock option and warrant programme, (B) an issue of warrants of series 2019/2022(A), and (C) an issue of warrants of series 2019/2022(B) and approval of transfers of warrants of series 2019/2022(B) 20190319
  •  Terms and conditions for warrants 2019/2022(B) 20190318
  •  Terms and conditions for warrants 2019/2022(A) 20190318
  •  Proposal to the annual general meeting of Episurf Medical AB (publ) to resolve on an issue of warrants of series 2019/2022(C) within an incentive programme for the board of directors 20190318
  •  Terms and conditions for warrants 2019/2022(C) Episurf Medical AB (publ) 20190318
  • Facebook
  • YouTube
  • Twitter
  • LinkedIn

ADDRESS Episurf Medical AB, Karlavägen 60, 114 49 Stockholm. Sweden

CONTACT info@episurf.com +46 (0)8 612 00 20

© Episurf 2023
By clicking or navigating this page, you agree to allow the use of cookies.Agree